[Federal Register Volume 84, Number 154 (Friday, August 9, 2019)]
[Notices]
[Pages 39383-39384]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17060]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2019-0154]
Release of Patients Administered Radioactive Material
AGENCY: Nuclear Regulatory Commission.
ACTION: Draft regulatory guide; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: On July 29, 2019, the U.S. Nuclear Regulatory Commission (NRC)
requested comments on draft regulatory guide (DG), DG-8057, ``Release
of Patients Administered Radioactive Material.'' The public comment
period was originally scheduled to close on August 26, 2019. The NRC is
extending the public comment period to allow more time for members of
the public to submit their comments.
DATES: The due date of comments requested in the document published on
July 29, 2019 (84 FR 36127) is extended. Comments should be filed no
later than September 26, 2019. Comments received after this date will
be considered, if it is practical to do so, but the Commission is able
to ensure consideration only for comments received on or before this
date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0154. Address
questions about NRC dockets IDs in Regulations.gov to Jennifer Borges;
telephone: 301-287-9127; email: [email protected]. For technical
questions, contact the individual listed in the FOR FURTHER INFORMATION
CONTACT section of this document.
Mail comments to: Office of Administration, Mail Stop:
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Vered Shaffer, Office of Nuclear
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 630-829-9862, email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2019-0154 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0154
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or
by email to [email protected]. The DG-8057 is available in ADAMS
under Accession No. ML19108A463.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
B. Submitting Comments
Please include Docket ID NRC-2019-0154, in your comment submission.
The NRC cautions you not to include identifying or contact information
that you do not want to be publicly disclosed in your comment
submission. The NRC will post all comment submissions at https://www.regulations.gov as well as enter the comment submissions into
ADAMS. The NRC does not routinely edit comment submissions to remove
identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Discussion
On July 29, 2019, the NRC published a document in the Federal
Register (84 FR 36127) requesting comments on DG-8057, ``Release of
Patients Administered Radioactive Material.'' This draft guide,
Revision 1, provides licensees with more detailed instructions to
provide to patients before and after they have been administered
radioactive material than was in Revision 0. In addition, the guide
includes a new section on ``Death of a Patient Following
Radiopharmaceutical or Implants Administrations,'' as well as
requirements for recordkeeping. Also, Table 3, ``Dosages of
Radiopharmaceuticals that Require Instructions and Records When
Administered to Patients who are Breastfeeding an Infant or Child,''
has been revised to provide information for the recommended duration of
interruption of breastfeeding to ensure that the dose to an infant or
child meets the NRC's regulatory requirements. The public comment
period was originally scheduled to close on August 26, 2019. The NRC
staff has decided to extend the public comment period on this document
until September 26, 2019, to allow more time for members of the public
to submit their comments.
Dated at Rockville, Maryland, this 6th day of August, 2019.
[[Page 39384]]
For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guidance and Generic Issues Branch, Division of
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2019-17060 Filed 8-8-19; 8:45 am]
BILLING CODE 7590-01-P